(Q41175249)

27 September 2017

1 reference

title

The growth without growth hormone syndrome (English)

1 reference

27 September 2017

Geffner ME

1

1 reference

27 September 2017

language of work or name

1 reference

1 September 1996

1 reference

Endocrinology and Metabolism Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

volume

25

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

649-663

1 reference

A unique growth factor in patients with acromegaloidism

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Decreased prolactin secretion in childhood obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Role of insulin-like growth factors in embryonic and postnatal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Circulating molecular variants of growth hormone in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Growth without growth hormone: the "invisible" GH syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Outcome in children with normal growth following removal of a craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Insulin-like Growth Factors I and II, Prolactin, and Insulin in 19 Growth Hormone-Deficient Children with Excessive, Normal, or Decreased Longitudinal Growth after Operation for Craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Craniopharyngiomas in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Craniopharyngioma: The Role of Insulin in Promoting Postoperative Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Engineering human prolactin to bind to the human growth hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Placental growth hormone variant: assay and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The genetic basis of dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Expression of the growth hormone variant gene in human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Growth without growth hormone: evidence for a potent circulating human growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Effects of growth hormone on body fat in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Gigantism with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

What Is the Role of Growth Hormone and Related Peptides in Implantation and the Development of the Embryo and Fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Insulin as a growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Normal growth with subnormal growth-hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Endocrinological Evaluation of GH Deficient Patient with Acromegaloidism Showing Excessive Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Human pituitary tissue secretes a potent growth factor for chondrocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Iatrogenic hypopituitarism in craniopharyngioma: Unexplained catch-up growth in three children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Endocrine function, morbidity, and mortality after surgery for craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Human growth hormone-variant is a biologically active somatogen and lactogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

1 reference

7 January 2021

Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Letter: Growth with absent growth hormone by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

FRACTIONAL HYPOPITUITARISM WITH GIANTISM AND NORMAL SELLA TURCICA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Exogenous human growth hormone reduces body fat in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Truncal vagotomy in hypothalamic obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Long-term follow-up of children with craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

The effect of simple obesity on growth and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Growth and development in simple obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Excessive growth in a child with craniopharyngioma and growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

48,XXYY syndrome associated with acromegaloidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Physiological role of the insulin-like growth factor binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

Hypopituitarism with normal or increased height. Report of two cases, with measurement of plasma growth hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970345-5

7 January 2021

10.1016/S0889-8529(05)70345-5

Identifiers

DOI

1 reference

27 September 2017

1 reference